Eli Lilly Trial Finds Alzheimer's Drug Can Slow Progress of Disease
Briefly

The drug manufacturer Eli Lilly announced on Wednesday that a clinical trial of an experimental Alzheimer's drug showed it can slow progress of the feared disease and allow patients to have more time when they can still live independently, performing tasks like cooking meals, going to the store and driving a car.
Read at www.nytimes.com
[
add
]
[
|
|
]